跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LENALIDOMIDA PIRAMAL 5 MG CAPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
LENALIDOMIDA PIRAMAL 5 MG CAPSULAS DURAS EFG
Approved
STANDARD
LENALIDOMIDA PIRAMAL 5 MG CAPSULAS DURAS EFG
Piramal Critical Care B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 23, 2021
Approval ID
3eb1cf387d0481c9
Company
Piramal Critical Care B.V.
Type
Standard
Approval Details
Approval Id
3eb1cf387d0481c9
Drug Cima Aemps Name
LENALIDOMIDA PIRAMAL 5 MG CAPSULAS DURAS EFG
Register Number
85867
Holder Company Name
Piramal Critical Care B.V.
Marketing Company Name
Euromed Pharma Spain S.L.
Holder Company Detail Path
/organization/piramal-critical-care-bv
Authorization Date
2021-03-23
Dosage Form
CÁPSULA DURA
Dose
5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Piramal Critical Care B.V.
Company Detail Path
/organization/piramal-critical-care-bv
Company Information
Pharmaceutical Company Name
Piramal Critical Care BV
Country Name
Netherlands
Website
http://www.piramal.com
Active Ingredients
LENALIDOMIDA
5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 23, 2021
Approval ID
3eb1cf387d0481c9
Type
Standard
Back to CIMA-AEMPS Approvals
